Dr. Kinase: Predicting the Drug resistance hotspots of Kinases

Prediction portal

Predict drug-resistance hotspots (Gatekeeper, G-loop, αC-helix, A-loop) in human kinase.

  Run prediction

Results

For coming-back users, go here to retrieve results from previous runs with Job IDs.

  Check results

Tutorial

Explanations for input/output formats and the usage of Dr. Kinase.

  Read tutorial

 3D structure

 Gatekeeper    A-loop    G-loop    αC-helix 

 About

Dr. Kinase builds upon our previously published studies (Hu R et al. NAR, 2021; Kim P et al. BIB, 2021) and utilizes the advantages of deep hybrid learning technology and multimodal features to predict actionable drug-resistance hotspots.

✦ The performance of Dr. Kinase has been rigorously evaluated using five-fold cross-validation and additional independent testing, demonstrating excellent accuracy with area under the curve (AUC) values exceeding 0.89 in different types of drug-resistance hotspot predictions.

✦ Additionally, Dr. Kinase provides comprehensive annotations and visualizations for the predicted results.

 Update

 Apr 12, 2025: Visualization of prediction results were updated.
 Apr 10, 2025: "Mutation mode" was added.
 Dec 18, 2024: Visualization of prediction results were added.
 Dec 14, 2024: This prediction platform and webserver were built.
 Oct 12, 2024: Prediction models were trained and tested.
 Aug 25, 2024: Drug resistance hotspots were annotated.
 Aug 10, 2024: Human kinase protein data were collected.

Developers:

Ruifeng Hu, Zhongming Zhao, Haodong Xu


Citation of our works:

♦ Dr. Kinase: Predicting the Drug resistance hotspots of Kinases using deep hybrid learning. Nucleic Acids Research.

♦ Hu R, Xu H, Jia P, Zhao Z. KinaseMD: kinase mutations and drug response database. Nucleic Acids Research. 49 (D1), D552-D561 [PMID: 33137204]

♦ Kim P, Li H, Wang J, & Zhao Z. (2021). Landscape of drug-resistance mutations in kinase regulatory hotspots. Briefings in Bioinformatics. 22(3), bbaa108. [PMID: 32510566]


License:

Dr. Kinase is licensed under CC BY-SA 4.0 .